Trial intelligence / Profile preview

Rivastigmine for brain mechanisms of cognitive fatigue in multiple sclerosis

2005-004909-29Phase 4Completed

Sponsor
Juhani Ruutiainen
Start
Dec 2005
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in multiple sclerosis (MS) comparing Rivastigmine with Placebo (2 arms). Started Dec 2005; status: completed.

02

Drugs

rivastigmine
03

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on 2005-004909-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004909-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call